<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: <z:hpo ids='HP_0000518'>Cataract</z:hpo> surgery in exudative <z:hpo ids='HP_0000554'>uveitis</z:hpo> is often followed by severe complications (pupillary seclusion/occlusion, dense posterior capsule/anterior vitreous opacification, <z:hpo ids='HP_0011505'>cystoid macular edema</z:hpo> following repeat YAG laser procedures) which often drastically limit functional recovery </plain></SENT>
<SENT sid="1" pm="."><plain>Total removal of <z:hpo ids='HP_0000518'>cataract</z:hpo>, anterior vitrectomy, and scleral fixation of a posterior chamber (PC) intraocular lens (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e>) has been tried as a surgical alternative, searching for lessened postsurgical complications and a better outcome </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Group A was a cohort of 12 patients with <z:hpo ids='HP_0000518'>cataract</z:hpo> after exudative (mostly <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> and Vogt-Koyanagi-Harada) <z:hpo ids='HP_0000554'>uveitis</z:hpo>, subjected to intracapsular <z:hpo ids='HP_0000518'>cataract</z:hpo> extraction, anterior vitrectomy, and scleral fixation of PC <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOLs</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Group B was the control group, including 12 patients with a similar clinical condition subjected to phacoemulsification or extracapsular <z:hpo ids='HP_0000518'>cataract</z:hpo> extraction plus in the- bag or in-the-sulcus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e> implantation </plain></SENT>
<SENT sid="4" pm="."><plain>Follow-up time for both groups was at least 7 years </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Postoperative inflammatory signs were substantially less in Group A patients, from 2 days up to &gt;7 years postsurgery </plain></SENT>
<SENT sid="6" pm="."><plain>Group A patients showed no cells/exudates adhering to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOL</z:e> surfaces, no <z:e sem="disease" ids="C0154933" disease_type="Disease or Syndrome" abbrv="">synechiae</z:e>, minimal (as compared to Group B) vitreous opacifications, and significantly higher visual acuity (p=0.024 at the seventh year control) </plain></SENT>
<SENT sid="7" pm="."><plain>Group A patients reported less frequent relapses of <z:hpo ids='HP_0000554'>uveitis</z:hpo> postsurgery, but the relevant clinical data did not allow statistical evaluations </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Total removal of <z:hpo ids='HP_0000518'>cataract</z:hpo> in highly exudative uveitic eyes, plus anterior vitrectomy and scleral fixation of PC <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IOLs</z:e>, although technically a more demanding surgical procedure, proved to be safe and more effective than classical procedures </plain></SENT>
</text></document>